And, while the diggers are at it, they should remember that companies touting their anecdotal evidence may have other agendas. Burd says that “we are constrained by current laws from increasing these incentives.” By that, he means the payments a company can give employees who, say, have stopped smoking are too small. “Reform legislation needs to raise the federal legal limits so that incentives can better match the true incremental benefit of not engaging in these unhealthy behaviors,” says Burd. Some emerging bills do contain such incentives. Are these good investments for taxpayers? Such op-eds, which are really another form of lobbying, don’t often answer that question.

If you'd like to get email from CJR writers and editors, add your email address to our newsletter roll and we'll be in touch.

Trudy Lieberman is a fellow at the Center for Advancing Health and a longtime contributing editor to the Columbia Journalism Review. She is the lead writer for The Second Opinion, CJR’s healthcare desk, which is part of our United States Project on the coverage of politics and policy. Follow her on Twitter @Trudy_Lieberman.